Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9498442
APP PUB NO 20140235662A1
SERIAL NO

14261337

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes rifaximin powder and to a process for preparing the same. The invention relates also to a pharmaceutical composition in solid form comprising said rifaximin, pharmaceutically acceptable excipients and optionally other ingredients. The compositions according to the invention are suitable for oral administration and are characterized by producing a controlled release of rifaximin, whereby a long-lasting effect is obtained in a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALFASIGMA S P A40133 BOLOGNA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barbanti, Maria Bologna, IT 10 31
Braga, Dario Bologna, IT 51 634
Confortini, Donatella Bologna, IT 48 681
Lauro, Vittoria Bologna, IT 4 22
Maffei, Paola Bologna, IT 23 122
Viscomi, Giuseppe Claudio Bologna, IT 82 622

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00